Esophagogastric Cancer clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Showing trials for
A Study of Amivantamab in People With Esophagogastric Cancer
Sorry, not currently recruiting here
The purpose of this study is to see whether the study drug, amivantamab, is an effective treatment for people with EGFR- or MET-amplified esophagogastric cancer. The researchers will also look at whether amivantamab is a safe treatment that causes few or mild side effects in participants.
Irvine, California and other locations